Treatment with tyrosine kinase inhibitors in patients with metastatic renal ... - UroToday PDF Print
UroTodayMulti-targeted tyrosine kinase inhibitors (MTKIs) are the standard in the treatment of metastatic renal cell carcinoma (mRCC).

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.